PERSPECTA

News from every angle

← Back to headlines

Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

24 Feb, 20:38 — 24 Feb, 20:38
PostShare
ℹOnly 1 source covers this story

Read at source (1 outlet)

seeking-alpha3d ago

Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

Read full article →

Related Stories

LTFRB suspends 3 transport network firms for violations

just now

Warner Bros. Discovery agrees to acquisition by Paramount Skydance

20m ago

Block's AI Strategy Amid Workforce Reductions

20m ago

In a Memoir Draft, Changpeng Zhao of Binance Details the Talks Leading to His Prison Time

51m ago